Authorized Chinese patents 53
|
NO. |
Title |
Patent Number |
Authorization Proclamation Date |
Areas |
| 1 |
Coffee Acyl Quinic Acid Derivative -1- Phosphate, Preparation and Application Thereof |
ZL200610020939.X | 2009-06-17 |
Preparation Process |
| 2 |
CHA Powder-injection and Preparation Method Thereof |
ZL201310366945.0 | 2015-04-15 |
Preparation Process |
| 3 |
Method for Preparation of Pharmaceutically Acceptable CHA |
ZL201410696450.9 | 2016-01-06 | Preparation Process |
| 4 |
Crystalline Form of CHA and Preparation Method Thereof |
ZL201410193699.8 | 2016-04-20 | Preparation Process |
| 5 |
Device for Enriching and Purifying Compound and Usage Thereof |
ZL201410720632.5 | 2016-04-20 | Preparation Process |
| 6 |
Method for Extracting CHA from Eucommia Leaves |
ZL201410186187.9 | 2016-08-17 | Preparation Process |
| 7 |
Pharmaceutical Composition, Preparation Method Therefor and Use Thereof |
ZL201310367050.9 | 2016-09-21 | Preparation Process |
| 8 |
Raw Material CHA or Raw Drug Chlorogenic Acid, Method for Preparing the Same and Method for Detecting Mass Thereof |
ZL201410193742.0 | 2017-11-07 | Preparation Process |
| 9 |
CHA Micro-emulsion and Preparation Process and Application Thereof |
ZL201510290957.9 | 2017-11-28 | Preparation Process |
| 10 |
CHA Chitosan Microsphere and Preparation Process and Application Thereof |
ZL201510290316.3 | 2018-04-17 | Preparation Process |
| 11 |
CHA Acylate for Improving Bioavailability of Chlorogenic Acid and Application Thereof |
ZL201510124457.8 | 2018-04-17 | Preparation Process |
| 12 |
CHA Freeze-dried Powder Injection with High Solubility and Stability |
ZL201510589448.6 | 2018-08-24 | Preparation Process |
| 13 | Application of CHA Derivative in Drug Quality Control | ZL201911019771.4 | 2022-04-08 | Preparation Process |
| 14 |
Derivative of 3- Caffeoyl Quinic Acid and Preparation Method and Application Thereof |
ZL201911019770.X | 2022-04-26 | Preparation Process |
| 15 |
Application of CHA in Preparing Medicine for Treating Small Cell Lung Cancer |
ZL200710140602.7 | 2009-11-11 |
Tumour |
| 16 |
Application of CHA in Preparation of Medicine for Preventing and Treating Nasopharyngeal Carcinoma |
ZL200610021897.1 | 2011-02-02 | Tumour |
| 17 |
Application of CHA in Cancer Control |
ZL201210086313.4 | 2014-02-19 | Tumour |
| 18 |
Application of CHA in Preparing Medicine for Treating Ependymoma |
ZL201410468334.1 | 2016-05-11 | Tumour |
| 19 |
Uses of CHA in the Preparation of Medicaments for Treatment of Oligodendroglioma |
ZL201410468312.5 | 2017-08-18 | Tumour |
| 20 |
Application of CHA in Preparing Medicine for Preventing and Treating Primary Cutaneous T Cell Lymphoma |
ZL201510079639.8 | 2019-03-12 | Tumour |
| 21 |
Pharmaceutical Composition for Treating Renal Cancer and Application Thereof |
ZL201810559399.5 | 2020-05-01 | Tumour |
| 22 |
Combined Medicine with Anti-tumor Effect |
ZL201710719094.1 | 2020-05-05 | Tumour |
| 23 |
Medicine for Combined Use in Cancer Treatment |
ZL201710719622.3 | 2020-06-12 | Tumour |
| 24 |
Application of Pharmaceutical Composition in Preparing Medicine for Treating Tumor Multidrug Resistance |
ZL201810206147.4 | 2020-06-12 | Tumour |
| 25 |
Application of CHA and Its Composition in Preparing Medicine for Treating Squamous Cell Carcinoma |
ZL201810449331.1 | 2020-06-12 | Tumour |
| 26 |
Combined Anti-tumor Medicine and Its Application in Preparing Anti-cancer Medicines |
ZL201710672267.9 | 2020-09-15 | Tumour |
| 27 |
Application of CHA and Its Composition in Preparing Medicine for Treating Sarcoma |
ZL201810374587.0 | 2020-10-20 | Tumour |
| 28 |
Combined Anti-tumor Medicine and Its Application in Preparing Anti-cancer Medicines |
ZL201710671362.7 | 2020-11-06 | Tumour |
| 29 |
Combined Medicine for Treating Diseases Related to Tumor Necrosis Factor Family |
ZL201710750731.1 | 2021-02-26 | Tumour |
| 30 |
Combined Anti-tumor Medicine and Its Application in Preparing Anti-cancer Medicines |
ZL201710671908.9 | 2021-03-09 | Tumour |
| 31 |
Combined Anti-tumor Medicine and Its Application in Preparing Anti-cancer Medicines |
ZL201710672289.5 | 2021-03-09 | Tumour |
| 32 |
Application of CHA in Preparing Medicine for Preventing or Treating Borderline Tumors |
ZL201811401684.0 | 2021-05-04 | Tumour |
| 33 |
Combined Medicine for Treating Tumors |
ZL201710752410.5 | 2022-02-11 | Tumour |
| 34 |
Combined Medicine for Treating B Lymphocyte-related Diseases |
ZL201710750728.X | 2022-04-12 | Tumour |
| 35 |
Combined Medicine and Its Application in Preparing Medicine for Treating High-grade Brain Tumor with Postoperative Recurrence and Ineffective Standard Treatment |
ZL201910024676.7 | 2022-04-12 | Tumour |
| 36 |
Application of CHA Composition in Preparing Medicine for Preventing or Treating Pain |
ZL202210115388.4 | 2023-10-13 | Tumour |
| 37 |
Application of CHA in Preparing Medicine for Medicine or Food for Resisting Anoxia |
ZL200710128491.8 | 2010-01-27 |
Blood |
| 38 |
Application of CHA in Preparing Medicine for Treating Thrombocytopenia and Anemia |
ZL200910246627.4 | 2011-07-13 | Blood |
| 39 |
Application of CHA in Preparing Medicine Protecting and Repairing Spleen Hematopoietic Stem Cell Injury |
ZL200910246134.0 | 2011-08-24 | Blood |
| 40 |
Application of CHA in Preparing Medicine with Effect of Increasing Bone Marrow Cells |
ZL200680024175.X | 2010-08-25 |
Cell Growth and Differentiation |
| 41 |
Application of CHA in Preparing Medicine for Treating Bone Marrow Fibrosis |
ZL200910246630.6 | 2011-09-07 |
Bones and Muscles |
| 42 |
Application of CHA in Preparing Medicine for Treating Bone Marrow Fibrosis |
ZL201510063970.0 | 2017-03-07 |
Bones and Muscles |
| 43 |
Compound Preparation for Treating Depression |
ZL201510579797.X | 2018-05-18 |
Nerve |
| 44 |
Drug Combination for Treatment of Amyotrophic Lateral Sclerosis, Preparation Method and Use Thereof |
ZL201810814892.7 | 2019-10-08 | Nerve |
| 45 |
Liver-protecting Medicine or Health-care Product Composition and Preparation Method and Application Thereof |
ZL201110386854.4 | 2013-07-10 |
Other Diseases |
| 46 |
Liver-protecting Medicine or Health-care Product Composition and Preparation Method and Application Thereof |
ZL201310210438.8 | 2014-11-05 |
Other Diseases |
| 47 |
Pharmaceutical Composition for Treating Hyperlipidemia and Preparation Method Thereof |
ZL2021105094626 | 2022-08-05 | Other Diseases |
| 48 |
Composition with Skin Repairing Effect |
CN202110956753.X | 2022-12-16 | Other Diseases |
| 49 |
Application of Pharmaceutical Composition Containing CHA in Preparing Medicine for Treating Pathological Jaundice |
ZL202110109946.1 | 2023-06-02 |
Other Diseases |
| 50 |
Application of CHA in Preparing Appetite-stimulating Medicine or Health Product |
ZL201611130322.3 | 2023-06-20 | Health Care |
| 51 |
Application of Injection Composition Containing CHA in Preparing Injection with Skin Whitening Effect |
ZL202110108965.2 | 2022-03-22 |
Cosmetic Medicine |
| 52 | Application of Pharmaceutical Composition in Preparing Medicine for Preventing and/or Treating Swine Diseases | ZL202011197072.1 | 2022-08-23 | Veterinary Use |
| 53 | Application of CHA Composition in Preparing Medicine or Feed Additives for Preventing and/or Treating Canine Parvovirus Disease and Canine Distemper | ZL202210115388.4 | 2023-11-24 | Veterinary Use |